India is the first major country after Canada where Novo is losing patent on semaglutide and will see an onslaught of generic versions ...
The appearance of stars at the Oscars 2026 has sparked debate over Hollywood’s growing reliance on Ozempic and other GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results